CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Japan Tissue Engineering Co., Ltd. is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Japan Tissue Engineering Co., Ltd.
6-209-1, Miyakita-dori
Phone: +81 533662020p:+81 533662020 GAMAGORI-SHI, ACH  443-0022  Japan Ticker: 77747774

Business Summary
Japan Tissue Engineering Co Ltd is a Japan-based company mainly engaged in regenerative medicine product business, regenerative medicine outsourcing business, and research and development support business. The Company operates through three segments. The Regenerative Medicine Product segment develops regenerative medicine products using tissue engineering, and manufactures and sells the products for medical institutions. The regenerative medicine products include autologous cultured epidermis JACE, and autologous cultured cartilage JACK. The Regenerative Medicine Outsourcing segment provides contract development and manufacturing organization (CDMO) services, contract research organization (CRO) services, consulting services, and contract manufacturing services for specific cell processed products. The Research and Development Support segment manufactures and sells human cultured tissues that apply advanced culture technology accumulated through the development of in-house products.
(Source: ARS)

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
12/31/20233/31/2023Yes----

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Executive President, Chief Executive Officer, Representative Director KenichiroHata 54 6/1/2020 12/1/2004
Senior Managing Executive Officer, Director ToshihiroOhsuka 66 6/1/2021 6/1/2004
Executive Officer, Director of Business Administration HiroakiMurai 6/1/2023 6/1/2023
8 additional Officers and Directors records available in full report.

Business Names
Business Name
7774
Japan Tissue Engineering Co., Ltd.

General Information
Number of Employees: 215 (As of 3/31/2023)
Outstanding Shares: 40,609,954 (As of 12/31/2023)
Shareholders: 11,201
Stock Exchange: TYO
Fax Number: +81 533662019


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Thursday, March 28, 2024